• EdU Imaging Kits (Cy3) in Pituitary Tumor Research

  2026-10-07

  EdU Imaging Kits (Cy3) offer a useful S-phase readout for interpreting pituitary tumor proliferation studies. This article examines how EdU imaging can distinguish DNA synthesis from viability, apoptosis, and pathway-level claims in research on the AS-IV–TUBB4B–STMN1–ERK axis.

• Heparin Affinity Chromatography and Cancer Stemness

  2026-10-07

  A source-grounded overview of how the HyperTrap Heparin HP Column may support biomolecular research related to CCR7–Notch1 signaling, while distinguishing supplier claims from published cancer biology evidence and highlighting limitations.

• EZ Cap™ Cy5 EGFP mRNA: Evidence & Limits

  2026-10-06

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) combines a Cap1-structured EGFP reporter with covalent Cy5 labeling for paired delivery and translation readouts. The design is useful for conceptual mRNA delivery and translation efficiency assay planning, but fluorescence signals do not by themselves establish intact cytosolic mRNA or therapeutic activity.

• URB597 and KDS-4103: Evidence in FAAH Research

  2026-10-06

  URB597, also known as KDS-4103, is a supplier-described selective FAAH inhibitor used as a pharmacological probe of endocannabinoid signaling. A 2026 mouse study found that cannabidiol reduced inflammatory pain and pain-related affective changes while altering FAAH, anandamide, cannabinoid-receptor, inflammatory, and serotonergic measures. However, that study did not test URB597, so its findings provide mechanistic context rather than direct evidence of URB597 efficacy. This overview compares the evidence, identifies conceptual applications in pain, neuroplasticity research, and neuroinflammation studies, and defines important translational limitations.

• Drug Response Metrics in Cancer: Beyond Viability

  2026-10-05

  Hannah Schwartz’s 2022 dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell killing are related but non-equivalent dimensions of anticancer drug response. This framework helps researchers interpret time-dependent drug effects more carefully and avoid treating reduced viability as definitive evidence of apoptosis or cell death.

• Chronic Stress, Mitochondria, and Depression-Like Behavior

  2026-10-05

  A 2025 rat study links chronic unpredictable mild stress with depression-like behavior, impaired mitochondrial function, and inflammatory signaling in the hippocampus and prefrontal cortex. Its key innovation was using a mitochondria-targeted antioxidant intervention to test whether oxidative imbalance contributes to the behavioral phenotype, while the findings remain limited to a preclinical animal model.

• Angiotensin (1-7) in Oral RAS Research

  2026-10-04

  A source-grounded overview of Angiotensin (1-7), its Mas receptor context, microbial generation by periodontopathogens, broader research applications, evidence strength, and translational limitations.

• From CCK-8 Signal to Translational Insight

  2026-10-03

  A thought-leadership analysis of how Cell Counting Kit-8 connects metabolic viability signals with translational research, using recent urothelial carcinoma findings to define evidence boundaries, validation strategies, and future opportunities.

• Prednisone Workflows for Immunology and Apoptosis

  2026-10-02

  Prednisone provides a practical way to model corticosteroid-driven lymphocyte suppression, G1 arrest, IL-2 pathway disruption, and apoptosis in controlled cell-based experiments. This workflow connects PHA-activated PBL assays with flow cytometry, cytokine measurements, neurodegeneration models, and metabolomics-informed quality control.

• VPS13A–XK Lipid Transfer: Structural Mechanism

  2026-10-01

  Hu and colleagues define how VPS13A delivers lipids to a membrane in partnership with the XK/XKR1 scramblase. Their cryo-EM structure and molecular dynamics simulations support a direct handoff from the VPS13A bridge-domain to the cytosolic membrane leaflet, followed by scramblase-mediated leaflet equilibration and membrane expansion.

• Merimepodib (VX-497): Assay Logic for IMPDH

  2026-10-01

  Merimepodib (VX-497) is a selective IMPDH inhibitor for studying guanine nucleotide dependence across antiviral, immunology, and oncology models. This article translates PEDV metabolism research into practical assay-design decisions, including rescue controls, orthogonal validation, and interpretation limits.

• 2-Deoxy-D-glucose: Practical Metabolic Workflows

  2026-09-30

  Build reproducible 2-DG experiments for glycolysis inhibition, cancer metabolism, and antiviral assays with concentration, timing, and control strategies that separate metabolic stress from nonspecific toxicity. The workflow also connects glucose restriction experiments with new lactate-signaling research, helping investigators design sharper mechanistic comparisons.

• MDV3100: From AR Blockade to Resistance Biology

  2026-09-30

  MDV3100 (Enzalutamide) offers a rigorous way to connect androgen receptor inhibition with emerging glycan and metabolic mechanisms of castration-resistant prostate cancer resistance.

• MLN4924 HCl Salt: A Translational Lens on RIPK3

  2026-09-29

  Neddylation connects protein turnover, viral immune evasion, and inflammatory cell death. This thought-leadership article explains how MLN4924 HCl salt can help translational researchers test whether cullin-RING ligase activity is required for viral RIPK3 degradation, while distinguishing established evidence from forward-looking hypotheses.

• Ceramides Drive RGNNV Replication Through Autophagy

  2026-09-29

  This study uses global lipidomics and pathway perturbation to show that red-spotted grouper nervous necrosis virus reshapes ceramide metabolism and exploits ceramide-dependent autophagy for replication. Its combination of lipid profiling, capsid-protein localization, genetic and pharmacological inhibition, and C16-ceramide rescue provides a useful framework for interpreting lipid–virus interactions while defining clear limits for cross-system translation.

8501 records 1/567 page Next 12345 下5页 Last page